End points in irritable bowel syndrome

Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):293-5. doi: 10.1586/egh.11.13.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Abdominal Pain / drug therapy
  • Abdominal Pain / etiology
  • Clinical Trials as Topic / methods*
  • Clinical Trials as Topic / standards
  • Constipation / drug therapy
  • Constipation / etiology
  • Diarrhea / drug therapy
  • Diarrhea / etiology
  • Drug Approval
  • Endpoint Determination*
  • Gastrointestinal Agents / therapeutic use*
  • Guidelines as Topic
  • Humans
  • Irritable Bowel Syndrome / complications
  • Irritable Bowel Syndrome / drug therapy*
  • Research Design* / standards
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Gastrointestinal Agents